{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: United Kingdom Healthcare news", "home_page_url": "https://sharemaestro.com/newsreel/gb/healthcare/", "feed_url": "https://sharemaestro.com/newsreel/gb/healthcare/feed.json", "description": "Latest Healthcare company headlines from United Kingdom, newest first, with industry sections, source links and company research.", "language": "en", "items": [{"id": "source:a1f8a31dbb0c21cb7a11e769baa5a77754496b677e017c291dc29a9edc9c6505", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE4ySlF1VDcxOFFVX180SEtKYjNWbi1FN3FkRFJIVVRSa1M3VS1nVVh0bWVkUVgzcU9yMXlaclVfcVQxUjNMRUdrQ3J2ZzN3ODFPcVRMTmsyMy0xaW83OXBEdVJxbU1QLTV0OGxETnJ6cHo4RFE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE4ySlF1VDcxOFFVX180SEtKYjNWbi1FN3FkRFJIVVRSa1M3VS1nVVh0bWVkUVgzcU9yMXlaclVfcVQxUjNMRUdrQ3J2ZzN3ODFPcVRMTmsyMy0xaW83OXBEdVJxbU1QLTV0OGxETnJ6cHo4RFE?oc=5", "title": "Thalia Therapeutics PLC Revenue Breakdown \u2013 LSE:THAT", "content_text": "Thalia Therapeutics PLC Revenue Breakdown \u2013 LSE:THAT", "date_published": "2026-08-14T01:46:45+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "THAT"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "THAT", "name": "Thalia Therapeutics Plc", "sentiment_url": "https://sharemaestro.com/sentiment/c28ab7d4-d7c3-411b-9d99-17587fd08379/"}]}}, {"id": "source:a69dad7f498c271b8e88673bb3dd96b3ed41570716cb301ad596799513432286", "url": "https://finance.yahoo.com/markets/stocks/articles/form-8-5-ept-ri-092300537.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/form-8-5-ept-ri-092300537.html", "title": "Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc", "content_text": "FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \"Code\") 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank Plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Advanced Medical Solutions Group Plc (c) Name of the party to the offer with which exempt principal trader is connected: Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc (d) Dat", "date_published": "2026-08-13T09:23:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "AMS"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMS", "name": "Advanced Medical Solutions Group plc", "sentiment_url": "https://sharemaestro.com/sentiment/df35c461-3170-4406-ae02-a9180e21faeb/"}]}}, {"id": "source:53504da76d9a12d742b2cba638899bae7f43870bc4394785907e534271e61ed8", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0tclctM3l0eExpaFViVjFUUVNRQW1HRjdxWHdLVDZDMExnR2RZdXRMSmE2dWxoOE5qZnlMMmRvVW8xV3R2MFR2VDhpeGtNVnVKWGxZ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0tclctM3l0eExpaFViVjFUUVNRQW1HRjdxWHdLVDZDMExnR2RZdXRMSmE2dWxoOE5qZnlMMmRvVW8xV3R2MFR2VDhpeGtNVnVKWGxZ?oc=5", "title": "Hikma Pharmaceuticals PLC (HIK.L) stock price, news, quote and history", "content_text": "Hikma Pharmaceuticals PLC (HIK.L) stock price, news, quote and history", "date_published": "2026-08-13T01:21:11+00:00", "authors": [{"name": "Market source"}], "tags": ["Market update", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:4f8597c4c8a062ce80d677b79a8a5b8c7ebb5ac203f8b7f70566a5287a7e0563", "url": "https://finance.yahoo.com/markets/stocks/articles/haleon-plc-cash-tender-offer-124800075.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/haleon-plc-cash-tender-offer-124800075.html", "title": "Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes", "content_text": "LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the \"Company\" or \"Haleon\") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the \"Offeror\") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Bondholders will receive a price equal to the Total Consideration based on the Reference Yield and the Fixed Spread plus Accrued Interest (each as defined below) (the \"Tender Offer\"). This Tender Offer is in line with Haleon's previously stated capital allocation priorities. Together, with the planned", "date_published": "2026-08-11T12:48:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Balance sheet", "HLN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HLN", "name": "Haleon plc", "sentiment_url": "https://sharemaestro.com/sentiment/223a8e29-bd20-45d7-a62a-3c8d1dee5ad0/"}]}}, {"id": "source:e8033883b9329c1ef1d49ef8c8e2b4272347f8c08f58ddb525349147875b279e", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNV0Z5WWZ5U2hsaWJnWUthSjFmUlhPZEtIeG82bEd4Z3V1NlE5X0pRNjJDTkZOdVRYNkR1UHBld3FxN3Y2ZE9ZTWtVZ0NZRWlpWkVwZm1kdXhaY0xrM183eG9qZ1Q4T2p0NUtNUGFGRjF6alA0MXp1TER5THdpX3dvWDFWRFZUYlp6c3hpV3EyNTVObThIcjhOQ2pDZ2FlYjllaFE1ZmQxbDZjOTZJbEhBdUJMeHg4NGgtMVI0RjFlam03eG9LWXl1akN0N2F0dV9mSGxuN2o3QTFFc3BxeDZFeUc2dDM?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNV0Z5WWZ5U2hsaWJnWUthSjFmUlhPZEtIeG82bEd4Z3V1NlE5X0pRNjJDTkZOdVRYNkR1UHBld3FxN3Y2ZE9ZTWtVZ0NZRWlpWkVwZm1kdXhaY0xrM183eG9qZ1Q4T2p0NUtNUGFGRjF6alA0MXp1TER5THdpX3dvWDFWRFZUYlp6c3hpV3EyNTVObThIcjhOQ2pDZ2FlYjllaFE1ZmQxbDZjOTZJbEhBdUJMeHg4NGgtMVI0RjFlam03eG9LWXl1akN0N2F0dV9mSGxuN2o3QTFFc3BxeDZFeUc2dDM?oc=5", "title": "Verici Dx plc (VRCI) Secures Olink Certification to Enhance Proteomics Services in Transplant Diagnostics", "content_text": "Verici Dx plc (VRCI) Secures Olink Certification to Enhance Proteomics Services in Transplant Diagnostics", "date_published": "2026-08-11T06:01:26+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "VRCI"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VRCI", "name": "Verici Dx plc", "sentiment_url": "https://sharemaestro.com/sentiment/fa544f82-9a09-42e5-8dc5-6311ba031c54/"}]}}, {"id": "source:a23d7187c41094ebe485bf28371a06b528c06e8cb7dd60726ff1b14122a96952", "url": "https://finance.yahoo.com/healthcare/articles/haleon-singapores-agency-science-technology-034100676.html", "external_url": "https://finance.yahoo.com/healthcare/articles/haleon-singapores-agency-science-technology-034100676.html", "title": "Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia", "content_text": "A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and healthy ageing in Asian populations. SINGAPORE, Aug. 11, 2026 /PRNewswire/ -- Haleon, a leading consumer health company focused on better everyday health, and the A*STAR Institute for Human Development and Potential (A*STAR IHDP) today announced the launch of a new clinical study known as the Impact of Mult", "date_published": "2026-08-11T03:41:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "HLN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HLN", "name": "Haleon plc", "sentiment_url": "https://sharemaestro.com/sentiment/223a8e29-bd20-45d7-a62a-3c8d1dee5ad0/"}]}}, {"id": "source:105c29e5353fcc2e2324c6279cd39185949fc6698d9b06e605c5b984c6e09471", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxOa2E2c3B6OGlxdHJnSHJVZW54Wmg5UFhCbWh6blp1MGZPMHFteG5qMUVaMW52dkdfVkNLSXpzbDNEYXRxVTFubGgtNFJ0a0xBOTF2cXo5SDdhallrTDRrTHN5M19HNXh5YTRYVWh3THJSV1VHYXRzcm5aYXExcHl5Zms2YmhDeWF1RUo5UkFGaUU5bUxNYnQ3cUQ4eEVlV3FjUUIyVmVQWTVsTlY2UVVuWXItYVByallfdDU4YXM0N3YzU2pYOEdpMEdrMW4xVjhRVF91LTQzOW1SUm50SzFOWlptU1lwODR5alNRVlZYUFlRcUxXdGFV?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxOa2E2c3B6OGlxdHJnSHJVZW54Wmg5UFhCbWh6blp1MGZPMHFteG5qMUVaMW52dkdfVkNLSXpzbDNEYXRxVTFubGgtNFJ0a0xBOTF2cXo5SDdhallrTDRrTHN5M19HNXh5YTRYVWh3THJSV1VHYXRzcm5aYXExcHl5Zms2YmhDeWF1RUo5UkFGaUU5bUxNYnQ3cUQ4eEVlV3FjUUIyVmVQWTVsTlY2UVVuWXItYVByallfdDU4YXM0N3YzU2pYOEdpMEdrMW4xVjhRVF91LTQzOW1SUm50SzFOWlptU1lwODR5alNRVlZYUFlRcUxXdGFV?oc=5", "title": "Hikma Pharmaceuticals (HIK) Buys Back 569,511 Shares in Week Ending 7 August 2026 as Part of $250 Million Repurchase Plan", "content_text": "Hikma Pharmaceuticals (HIK) Buys Back 569,511 Shares in Week Ending 7 August 2026 as Part of $250 Million Repurchase Plan", "date_published": "2026-08-10T14:20:41+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Capital return", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:732e648d0f0de85d1e3286ff1e7e89675cabff8b556811c216be3d1f3854b384", "url": "https://finance.yahoo.com/video/immupharma-valirx-tertiary-minerals-caledonia-075214482.html", "external_url": "https://finance.yahoo.com/video/immupharma-valirx-tertiary-minerals-caledonia-075214482.html", "title": "ImmuPharma, ValiRx, Tertiary Minerals, Caledonia Mining, Sintana Energy - Small Cap Snapshot", "content_text": "ImmuPharma PLC (AIM:IMM, FRA:25I) has signed up Kymos Group as its bioanalytical partner for diabetes drug Kapiglucagon. That completes the outsourced team needed to file for human trials in the US. ValiRx PLC (AIM:VAL, FRA:EAJF) is set to get a second European patent for its cancer-killing peptide from subsidiary Cytolytix. It's targeting triple negative breast cancer and is in talks with a major pharma company. Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU) has drilled some strong copper and silver hits at its Mushima North project in Zambia. Lab results are due in the coming weeks, with a resource estimate targeted by the end of the year. Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) has kept its 2026 gold production target after output jumped 18% quarter on quarter. Revenue, profit and earnings per share were all up sharply too. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) will talk to shareholders after a third voted against its new equity pay plan. All resolutions still passed, and the CEO says big catalysts are coming over the next year. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk. View Comments", "date_published": "2026-08-10T07:52:14+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "IMM", "VAL"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IMM", "name": "ImmuPharma plc", "sentiment_url": "https://sharemaestro.com/sentiment/59b37edd-e336-4665-992e-68d8ca6142c3/"}, {"symbol": "VAL", "name": "ValiRx plc", "sentiment_url": "https://sharemaestro.com/sentiment/a14b38a9-5f7b-46fc-b303-50dd77328cfa/"}]}}, {"id": "source:4ad215a1dc921952691f021db5ac0dc3c9d9a2120ce7b9519eebe4ddc0cfbd2a", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQYUNtNnowQjVyanhQMEtYOHBPX0lQdGoxSkc5QW5nMVdpWlhFbXdvbFRkTnpKQXpXWlFEUjFqb3VxNXkyaGk5bm1yeUhTanRtSklCcGx5X1ZON1NKRW1DLUFFRjkyT3ZqT3MzMDlnTTVIRkhPODA2UUwtdFJ2T2RHeFhQeU5kN2ZTM2hXVGhJbTFjamd0Qm40RG5LQzZSMDNFQUtFcVRYVzdKQWIzdnBtcVBYQjNTVFhneWVNWnB3NkNlTkd4cGZtTHBaZzR3cldEZlE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQYUNtNnowQjVyanhQMEtYOHBPX0lQdGoxSkc5QW5nMVdpWlhFbXdvbFRkTnpKQXpXWlFEUjFqb3VxNXkyaGk5bm1yeUhTanRtSklCcGx5X1ZON1NKRW1DLUFFRjkyT3ZqT3MzMDlnTTVIRkhPODA2UUwtdFJ2T2RHeFhQeU5kN2ZTM2hXVGhJbTFjamd0Qm40RG5LQzZSMDNFQUtFcVRYVzdKQWIzdnBtcVBYQjNTVFhneWVNWnB3NkNlTkd4cGZtTHBaZzR3cldEZlE?oc=5", "title": "CVS Group (CVSG) Completes Buyback of 194,132 Shares at Up to 1,303.5p in Latest Weekly Update", "content_text": "CVS Group (CVSG) Completes Buyback of 194,132 Shares at Up to 1,303.5p in Latest Weekly Update", "date_published": "2026-08-10T06:01:16+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Capital return", "CVSG"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CVSG", "name": "CVS Group plc", "sentiment_url": "https://sharemaestro.com/sentiment/5246d19d-3a49-4ee1-aad0-4c4cd5866e7b/"}]}}, {"id": "source:aebca00c14c57be187ce8a0d289061542fe90035531e6130e76275598ea52a8f", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Two Days Left To Buy Hikma Pharmaceuticals PLC (LON:HIK) Before The Ex-Dividend Date", "content_text": "Two Days Left To Buy Hikma Pharmaceuticals PLC (LON:HIK) Before The Ex-Dividend Date", "date_published": "2026-08-10T05:09:45+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:2ce674b337483eaa8cdb7407eb2350e4630b953f63dafef1c2bbd3a4558cba28", "url": "https://finance.yahoo.com/healthcare/articles/astrazeneca-lse-azn-signs-two-151237153.html", "external_url": "https://finance.yahoo.com/healthcare/articles/astrazeneca-lse-azn-signs-two-151237153.html", "title": "AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access", "content_text": "Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. SOPHiA GENETICS and AstraZeneca (LSE:AZN) have entered a global partnership to develop and launch two decentralized companion diagnostics in precision oncology. The multi-year collaboration focuses on clinical trial assays that support development and commercialization of AstraZeneca's oncology therapies. The partners aim to expand access to personalized cancer treatments by enabling decentralized testing across a wider range of clinical settings. For readers tracking how data driven tools are changing drug discovery and cancer care, it is worth looking more broadly at the companies building these capabilities through 6 healthcare AI stocksLSE:AZN Earnings & Revenue Growth as at Aug 2026 AstraZeneca sits among the large global pharmaceutical companies with a strong focus on oncology, so investors often watch how new partnerships align with that core specialty. The stock trades at \u00a3118.96 and has been volatile recently, with the share price down over the past week and month, yet still showing gains over the past year and over multi year periods. Beyond the headline: 2 risks and 4 things going right for AstraZeneca that every investor should see. How does this SOPHiA GENETICS deal actually change things for AstraZeneca? The agreement gives AstraZeneca access to SOPHiA GENETICS's decentralized Solid Tumor and Hematological Oncology diagnostic platforms for use as companion diagnostics. That links AstraZeneca's oncology drugs directly to assays that can run in a wider range of hospitals, not only in central labs. For AstraZeneca, this can support uptake of existing and future cancer therapies where treatment decisions rely on accurate biomarker testing, and it ties real world data generation more tightly to its portfolio. What does this mean for the AstraZeneca oncology Narrative? The Narrative around AstraZeneca centers on oncology approvals, late stage assets such as Datroway and Sone Ve, and use of data and technology to support precision medicine. Partnering with SOPHiA GENETICS fits that story by building the diagnostic side needed for targeted drugs to reach the right patients. It also sits alongside other alliances like Pathos AI, reinforcing a pattern of AstraZeneca using external platforms to support its R&D and commercial ambitions rather than relying only on internal tools. What should investors watch next from this diagnostics partnership? The key marker will be when the first SOPHiA based companion diagnostic linked to an AstraZeneca therapy is validated and cleared by regulators in a major market such as the US or EU. Concrete updates on regulatory submissions, specific cancer indications covered, and uptake of decentralized assays in clinical trial settings will show whether this collaboration is translating into broader real world use of AstraZeneca's oncology drugs. Story Continues For the full picture including more risks and rewards, check out the complete AstraZeneca analysis. Alternatively, you can check out the community page for AstraZeneca to see how other investors believe this latest news will impact the company's narrative. Do you think there's more to the story for AstraZeneca? Head over to our Community to see what others are saying! This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AZN.L. Have feedback on this ", "date_published": "2026-08-08T15:12:37+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "AZN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AZN", "name": "AstraZeneca PLC", "sentiment_url": "https://sharemaestro.com/sentiment/a8a1958e-2ccb-4df7-bc10-bc89c0a4f6e7/"}]}}, {"id": "source:1541c519655725ad3b0a5c9bb85605c8731b3eba62738296f639b85ce5083012", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPQUJObFJ1ZW5nZVZFek1iejlPM3RadzVOX1VLcGtoeGwxNFZGZ1BrTkxqd1NaQ3BUWkpTeUpBcFRCYmM3NmdnZm01SHZmZUJkVWQ5amVweXN0QlNuSFF5SjgtNmVFRXFxZ0dDdXV0OEs2anF6ZGZXS29MZm9NdXRvUmc0SUoxZWZR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPQUJObFJ1ZW5nZVZFek1iejlPM3RadzVOX1VLcGtoeGwxNFZGZ1BrTkxqd1NaQ3BUWkpTeUpBcFRCYmM3NmdnZm01SHZmZUJkVWQ5amVweXN0QlNuSFF5SjgtNmVFRXFxZ0dDdXV0OEs2anF6ZGZXS29MZm9NdXRvUmc0SUoxZWZR?oc=5", "title": "Hikma Pharmaceuticals rallies on improving trends", "content_text": "Hikma Pharmaceuticals rallies on improving trends", "date_published": "2026-08-07T14:20:51+00:00", "authors": [{"name": "Investors' Chronicle"}], "tags": ["Market update", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:7aa993b35be1fac61cd5021bed9cabb943f7cf46bd6581853c89d60758ed6488", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPa01tM0RIX1N5b1FyaDk4UFF3bnFvTnYzSndfLTRDNFZSUHZOd1J2UE5fcVdzaU1hRkhTaHctZEJITFBPZEI1YUo5VThVNWNrTTIxdjFkcXhhOVBlVjRhYWxUSXN3dHRXMzNMNVVZbVVzekdEcms4Y0U1eUlKUXZScFhiWmlVNGpTY1RESTJPVWhyOWFBbF85SkhFcXJicEtULUgtUE0xb0x1OHg2NndKMjBvLXg0Y21GTUFISDFJQ25uLXE1bXlNOFhDWG1hdEE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPa01tM0RIX1N5b1FyaDk4UFF3bnFvTnYzSndfLTRDNFZSUHZOd1J2UE5fcVdzaU1hRkhTaHctZEJITFBPZEI1YUo5VThVNWNrTTIxdjFkcXhhOVBlVjRhYWxUSXN3dHRXMzNMNVVZbVVzekdEcms4Y0U1eUlKUXZScFhiWmlVNGpTY1RESTJPVWhyOWFBbF85SkhFcXJicEtULUgtUE0xb0x1OHg2NndKMjBvLXg0Y21GTUFISDFJQ25uLXE1bXlNOFhDWG1hdEE?oc=5", "title": "UK's Oxford Biomedica tumbles after annual revenue forecast cut", "content_text": "UK's Oxford Biomedica tumbles after annual revenue forecast cut", "date_published": "2026-08-07T13:43:25+00:00", "authors": [{"name": "Reuters"}], "tags": ["Earnings", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:b39a1c6b33b0c763c42e5f09039531d05a35b03984212940fc25b555d9cc137e", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQN19SZk9Zdl90ckxEYVRjUE5XNmVsdHJ4ekhXb0gtRFA4eVNyYnhCNUJJMkJCck1iY2VVLUZuTEFNNmwxN1FyMDVFZ2hhLTkxaUNEUGVVQkc2UEdMTURFV045ZVlaOGt4bUw4emx5c2UxUVJPQ2o2czFYNE96dnN6eEdXb2JxODNobGdmb2h6YjNHVXE1MzQ5QjhJR0R6YmVRZnNLR0VYY2ZOUi00TFNsag?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQN19SZk9Zdl90ckxEYVRjUE5XNmVsdHJ4ekhXb0gtRFA4eVNyYnhCNUJJMkJCck1iY2VVLUZuTEFNNmwxN1FyMDVFZ2hhLTkxaUNEUGVVQkc2UEdMTURFV045ZVlaOGt4bUw4emx5c2UxUVJPQ2o2czFYNE96dnN6eEdXb2JxODNobGdmb2h6YjNHVXE1MzQ5QjhJR0R6YmVRZnNLR0VYY2ZOUi00TFNsag?oc=5", "title": "Hikma Pharmaceuticals shares jump as margin-led profit beat tops forecasts", "content_text": "Hikma Pharmaceuticals shares jump as margin-led profit beat tops forecasts", "date_published": "2026-08-07T11:13:45+00:00", "authors": [{"name": "AskTraders"}], "tags": ["Earnings", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:a81421e0558e357447edc99db6f3d4e0ca429c7c7e587a214d2e723363c22cc7", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPc1Z1b0R2RzNoUExEc3UxTVBFd1g0cHRoU2NqbnV6aTduazFNR0FrcWJSZFE1NzR6QkRGdTcyMG9aRGxiZUVkd0FlNHF3ME9xTmpxYkFSQnhJWmJMbVZCNmtIZERYY0s2Sm5xVjV3RzJoeFpYMmpkY2YtY2k4ZWRfclVnc2FVLTh2YTE1UDZQNnFVNkpaTXNpWEpYNjFId1FCdThZVDAtLVRUb191WlJCSWdvUlAwNzNlTjBWdzBLUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPc1Z1b0R2RzNoUExEc3UxTVBFd1g0cHRoU2NqbnV6aTduazFNR0FrcWJSZFE1NzR6QkRGdTcyMG9aRGxiZUVkd0FlNHF3ME9xTmpxYkFSQnhJWmJMbVZCNmtIZERYY0s2Sm5xVjV3RzJoeFpYMmpkY2YtY2k4ZWRfclVnc2FVLTh2YTE1UDZQNnFVNkpaTXNpWEpYNjFId1FCdThZVDAtLVRUb191WlJCSWdvUlAwNzNlTjBWdzBLUQ?oc=5", "title": "Oxford BioMedica shares fall after delays impact revenue expectations", "content_text": "Oxford BioMedica shares fall after delays impact revenue expectations", "date_published": "2026-08-07T10:18:15+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:da06ec4a61d3704a5181f7b8fffea4f59ec1916eebbbfd474def79f55e2b35ca", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTTRmb2xES056c21MWWtlSVFOeTJpSDNpYmxpM0xSUTlRTnRGVmx0U3RuTkdHTGlQTjhRZXgxMlUxbVF4OFZsTjJ3WXJpLWJJSnppM3lRenk0TU4wOUJVSm44ZGhUSTg3QTRNLU5sdmVxbG4zOVZxcmp3b3ZmQmw4T29RNThtQlpDajhXYWlCenNuRkNGTmN6c3RzSHBhcjI2YmJtdGE0Y20tcExEVG1tQThYZ0tZd0FG?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTTRmb2xES056c21MWWtlSVFOeTJpSDNpYmxpM0xSUTlRTnRGVmx0U3RuTkdHTGlQTjhRZXgxMlUxbVF4OFZsTjJ3WXJpLWJJSnppM3lRenk0TU4wOUJVSm44ZGhUSTg3QTRNLU5sdmVxbG4zOVZxcmp3b3ZmQmw4T29RNThtQlpDajhXYWlCenNuRkNGTmN6c3RzSHBhcjI2YmJtdGE0Y20tcExEVG1tQThYZ0tZd0FG?oc=5", "title": "WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view", "content_text": "WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view", "date_published": "2026-08-07T09:21:52+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:57101df9264eac61469f79f130b0b5ba748ba76f1cb40a3bc017296e0a84ac0f", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNa3lJb0NMU21mRG83T1BPNmtuLTBQcEhOLWRMZENYWGNQUEE1a1B3cWZLVFM5VWJnMzkyMVR4U3FTYWN4bTFEVTBLcDI0V1lZNWcwcFJRTkp5ckk3R2I2WFV4M2lvRUY4bHJTZDRRWmR3NFp1Um43U01KZFdRQUxQMFBlSnFrT0pMYmNwcU1BMWVtUWVtSEYyRlhkUmNRSWRZSGlUSUl2VWNVZXV0aDN4Y29uWTBpUEpqbG5Sb0Y3OWNUd3pCb00tc0NjUTNRVXJhbUpGTQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNa3lJb0NMU21mRG83T1BPNmtuLTBQcEhOLWRMZENYWGNQUEE1a1B3cWZLVFM5VWJnMzkyMVR4U3FTYWN4bTFEVTBLcDI0V1lZNWcwcFJRTkp5ckk3R2I2WFV4M2lvRUY4bHJTZDRRWmR3NFp1Um43U01KZFdRQUxQMFBlSnFrT0pMYmNwcU1BMWVtUWVtSEYyRlhkUmNRSWRZSGlUSUl2VWNVZXV0aDN4Y29uWTBpUEpqbG5Sb0Y3OWNUd3pCb00tc0NjUTNRVXJhbUpGTQ?oc=5", "title": "Oxford BioMedica tanks 24% after earnings alert; brokers take stock", "content_text": "Oxford BioMedica tanks 24% after earnings alert; brokers take stock", "date_published": "2026-08-07T08:03:00+00:00", "authors": [{"name": "Proactive Investors"}], "tags": ["Earnings", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:722fe53b120318b2a094299c5e6ab23d96b695664e6e7929cd251f7238de08a8", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYTlmektEdXpFUGxETkppVE1ET29yNEVGVzBsYlJYSTFNWC1aSm15S0l0VDlfWm8zVGJmQjFZYXhWa1hONXY4SmNQUXJOSTdIb3BwMzRxbm5xZ0pmZWNGTlVqZ2ZraV9lVGhDam4yS25iNHFHeVJ1QVdzM2YtNEVXaV9SNXExYm8tZVFTNFZJLTZocTFHWDZvcWJpY0tmX3Ez?oc=5", "external_url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYTlmektEdXpFUGxETkppVE1ET29yNEVGVzBsYlJYSTFNWC1aSm15S0l0VDlfWm8zVGJmQjFZYXhWa1hONXY4SmNQUXJOSTdIb3BwMzRxbm5xZ0pmZWNGTlVqZ2ZraV9lVGhDam4yS25iNHFHeVJ1QVdzM2YtNEVXaV9SNXExYm8tZVFTNFZJLTZocTFHWDZvcWJpY0tmX3Ez?oc=5", "title": "Oxford Biomedica Shares Slump on Deep FY2026 Revenue Downgrade", "content_text": "Oxford Biomedica Shares Slump on Deep FY2026 Revenue Downgrade", "date_published": "2026-08-07T07:43:51+00:00", "authors": [{"name": "AskTraders"}], "tags": ["Earnings", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:9984a003cedcbe2cef27725fa8c64a76f3e49f8f9d664123b860e2608b6310da", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQN0xkeElNYnV5RENWa0ZZZGV5a2xwMTFDT2F2OHVVSWpJQUptXy0tZTFUSWNRTHFSUmlVVXF0UjV4c1MtWk5jOGliMXZ4ekx0YmdmWndzNWpUcGQxZDdNSUM2TmxXR0NtUFRpWWVQM2xrZUhSMGQ0X3V0RnNYQnd0VlhXN2pTY1VibndNR1BuNA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQN0xkeElNYnV5RENWa0ZZZGV5a2xwMTFDT2F2OHVVSWpJQUptXy0tZTFUSWNRTHFSUmlVVXF0UjV4c1MtWk5jOGliMXZ4ekx0YmdmWndzNWpUcGQxZDdNSUM2TmxXR0NtUFRpWWVQM2xrZUhSMGQ0X3V0RnNYQnd0VlhXN2pTY1VibndNR1BuNA?oc=5", "title": "Oxford Biomedica Lowers 2026 Guidance Despite Strong Client Growth", "content_text": "Oxford Biomedica Lowers 2026 Guidance Despite Strong Client Growth", "date_published": "2026-08-07T07:32:19+00:00", "authors": [{"name": "Market source"}], "tags": ["Guidance", "OXB"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OXB", "name": "Oxford Biomedica plc", "sentiment_url": "https://sharemaestro.com/sentiment/95def50f-c78f-4cc2-9794-e66d3b39f20d/"}]}}, {"id": "source:487785869d12e8bb5b1a13bdffbbff8bf38c80135a1765aacb91e073200bd1e0", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQcTl0Z3RobnEzVThPeFI3eUg2VlFmcTJBRVFYNVpiaWxSb2lianpJYVFKekJuNXlrVExrRWFnQzREM1o0M2I3WVNudEpFMGVjSmNxTW85bEMyNS1SQThULWV1OF9Kazg0bVduaW4tZExybEl6NC1XS0lIUjJnd0hpZnlvWFBlTXkwYTA2eUdtMWMwekJWN2JKSkVqcXVhdFpFUnpEMVNmSFRtOWdHUXc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQcTl0Z3RobnEzVThPeFI3eUg2VlFmcTJBRVFYNVpiaWxSb2lianpJYVFKekJuNXlrVExrRWFnQzREM1o0M2I3WVNudEpFMGVjSmNxTW85bEMyNS1SQThULWV1OF9Kazg0bVduaW4tZExybEl6NC1XS0lIUjJnd0hpZnlvWFBlTXkwYTA2eUdtMWMwekJWN2JKSkVqcXVhdFpFUnpEMVNmSFRtOWdHUXc?oc=5", "title": "Hikma Pharmaceuticals PLC 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:HKMPY) 2026-08-06", "content_text": "Hikma Pharmaceuticals PLC 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:HKMPY) 2026-08-06", "date_published": "2026-08-06T17:50:55+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Earnings", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:d5a106a893d0c780fa103ad61f92eb1c5c78a99033d379c74cf83c6d7f1deaa5", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOQWhNcEVlYkZYczdpbjFuTmo2UVdxU1NTMUVvVkVya3VRejVhNTBiTm85RzBkMnBXWC1kZFIyeFVBR2x2Vy1zY2l2aHBYcjF2Z0V1TWd2aEstYXVmX2VHLXBOV2h3M0YzS0pvbTlFaTB6RHl6eGxlanhpeEp6d0VSaVNjT1J5U2ROV1E3TUNqNktrbEU4ZkNRNHh6YUl6VzJMNVhuVGFB?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOQWhNcEVlYkZYczdpbjFuTmo2UVdxU1NTMUVvVkVya3VRejVhNTBiTm85RzBkMnBXWC1kZFIyeFVBR2x2Vy1zY2l2aHBYcjF2Z0V1TWd2aEstYXVmX2VHLXBOV2h3M0YzS0pvbTlFaTB6RHl6eGxlanhpeEp6d0VSaVNjT1J5U2ROV1E3TUNqNktrbEU4ZkNRNHh6YUl6VzJMNVhuVGFB?oc=5", "title": "Oxford Nanopore (LSE:ONT) Reflects the Genomics Growth Theme", "content_text": "Oxford Nanopore (LSE:ONT) Reflects the Genomics Growth Theme", "date_published": "2026-08-06T12:48:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "ONT"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ONT", "name": "Oxford Nanopore Technologies plc", "sentiment_url": "https://sharemaestro.com/sentiment/c1d5de20-bb9c-478b-b643-c7dc8ae9ec99/"}]}}, {"id": "source:55104e56b47bc37a9b21466a54d3f1c2b177b336ba3f81ef4e43b4a0af14cd16", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNUVRSbzNSeGFieW81WElCal96a1JlMWFVenAxRmR1TVZlRHlSSzJtczd2aGVzWTRKQ3k0Q050dlNnakV3VFNGSVRtX1NwR0pTZlVQTjk3dXJDWm5nUVFhM1VxdUlFN3FlSm5WWXgxNGJ6QU9VWk1ySUVtUDF0eHUyUkdTRFRkVHBkRDc1OXUtQ0VIamdTSU51Mzk4R0dRWG9McHVYRDZmc1A4a1Q2ZGtmczF2b1pnbW5PZEZrVXNR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNUVRSbzNSeGFieW81WElCal96a1JlMWFVenAxRmR1TVZlRHlSSzJtczd2aGVzWTRKQ3k0Q050dlNnakV3VFNGSVRtX1NwR0pTZlVQTjk3dXJDWm5nUVFhM1VxdUlFN3FlSm5WWXgxNGJ6QU9VWk1ySUVtUDF0eHUyUkdTRFRkVHBkRDc1OXUtQ0VIamdTSU51Mzk4R0dRWG9McHVYRDZmc1A4a1Q2ZGtmczF2b1pnbW5PZEZrVXNR?oc=5", "title": "Creo Medical (LSE:CREO) Moves the Penny-Stock Focus From Approval to Clinical Habit", "content_text": "Creo Medical (LSE:CREO) Moves the Penny-Stock Focus From Approval to Clinical Habit", "date_published": "2026-08-06T12:26:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Regulatory and legal", "CREO"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CREO", "name": "Creo Medical Group PLC", "sentiment_url": "https://sharemaestro.com/sentiment/b6045b68-01d3-4d73-8970-5837efe45dac/"}]}}, {"id": "source:493ed37be4e7e2349fddddfa66cee8e309eab3c0d9b3249074617459777075ae", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOSDRSb09mOTI3N0dfaTY3SnFOUVhSWjlkVUhCS1JtWk9BZVY1dFJzenRIUWpLOVJMV1VDX29FRVpESW5nWHFtbDdGTmN2SHZ4N2d5WTRtT3ZqZlNzQUxVN3ZzZmRYN0MwdWpiVmEwQ0p5S1NlcDhGUmRPOXBGU3hRNnlYclRJb1E3VlFQUnV5VGNxbXVjR2ROU3pWLW01Q1lkVXZqbmdycG0wLVI2dU5VLWlqbXNvUHAtbFVBRm5lLUcwUVpJ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOSDRSb09mOTI3N0dfaTY3SnFOUVhSWjlkVUhCS1JtWk9BZVY1dFJzenRIUWpLOVJMV1VDX29FRVpESW5nWHFtbDdGTmN2SHZ4N2d5WTRtT3ZqZlNzQUxVN3ZzZmRYN0MwdWpiVmEwQ0p5S1NlcDhGUmRPOXBGU3hRNnlYclRJb1E3VlFQUnV5VGNxbXVjR2ROU3pWLW01Q1lkVXZqbmdycG0wLVI2dU5VLWlqbXNvUHAtbFVBRm5lLUcwUVpJ?oc=5", "title": "Smith & Nephew (LON:SN) Price Target Lowered to GBX 1,290 at JPMorgan Chase & Co.", "content_text": "Smith & Nephew (LON:SN) Price Target Lowered to GBX 1,290 at JPMorgan Chase & Co.", "date_published": "2026-08-06T10:37:08+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Analyst action", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:ac44c7610ccc9bba4570c5558b488b9870ae2129a85d5a2097723bd3fee87e34", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQSEVtNEtnR3cxVmR0am1lRHhiZXY0cnRzc0tEUmhyMUhVckFSem9ZQjlRb1V2YWVfQU5LSFhZM3diN0lMbVJ0aEh1X1RVVUdick1NbHJORHN0Y01VMWdlUXVKelBQenFPVzR1b2lWTWtQRzB6V0ZkTlI5dkNYVldnT1lwcnZsVGl6bmVqWjZUYW16VnJKQTNGclMtTEZXOTltdEd1ZG5GT25xSmdHZ2ZkdUFlXzE4NlhhU0MwZQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQSEVtNEtnR3cxVmR0am1lRHhiZXY0cnRzc0tEUmhyMUhVckFSem9ZQjlRb1V2YWVfQU5LSFhZM3diN0lMbVJ0aEh1X1RVVUdick1NbHJORHN0Y01VMWdlUXVKelBQenFPVzR1b2lWTWtQRzB6V0ZkTlI5dkNYVldnT1lwcnZsVGl6bmVqWjZUYW16VnJKQTNGclMtTEZXOTltdEd1ZG5GT25xSmdHZ2ZkdUFlXzE4NlhhU0MwZQ?oc=5", "title": "JPMorgan cuts Smith & Nephew stock rating on market slowdown By Investing.com", "content_text": "JPMorgan cuts Smith & Nephew stock rating on market slowdown By Investing.com", "date_published": "2026-08-06T09:26:00+00:00", "authors": [{"name": "Investing.com UK"}], "tags": ["Analyst action", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:62167fd1fe6f11e807715e1d0d54de1c636bd520be2de6d7085e64f569b3d72a", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQb1JMdzkwSzVNTGdqOXRXZjUzQ2tLeFk5SXR1bkEtNkZWeElUYTRjSjRPaXBySEhqVWV5Mjh0aE9KWmd3QkRDZWgwMVBoeDJtcmxYTTJNZUMzZ2R5WF9nTVJkcWFIaDQzTGF5ZzlsSkdoeEV1dEJPQmM0bVNnQXBibkk4cEYwY1pHWTFucmFia2VCeW1xZUVTRVkzdlBBS3BVOE9VV3BIRk9NSG1vNkJtc2dlcDRWc1ZUNHZIWGM3c1pjRkhEYTI5WW00dHg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQb1JMdzkwSzVNTGdqOXRXZjUzQ2tLeFk5SXR1bkEtNkZWeElUYTRjSjRPaXBySEhqVWV5Mjh0aE9KWmd3QkRDZWgwMVBoeDJtcmxYTTJNZUMzZ2R5WF9nTVJkcWFIaDQzTGF5ZzlsSkdoeEV1dEJPQmM0bVNnQXBibkk4cEYwY1pHWTFucmFia2VCeW1xZUVTRVkzdlBBS3BVOE9VV3BIRk9NSG1vNkJtc2dlcDRWc1ZUNHZIWGM3c1pjRkhEYTI5WW00dHg?oc=5", "title": "Inspiration Healthcare grants performance-linked share options to top executives", "content_text": "Inspiration Healthcare grants performance-linked share options to top executives", "date_published": "2026-08-06T07:00:00+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "IHC"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IHC", "name": "Inspiration Healthcare Group plc", "sentiment_url": "https://sharemaestro.com/sentiment/663bc40a-4edd-4766-8bb2-ebb00caf684b/"}]}}, {"id": "source:c64df59a63f330372f2f43664102f1632c2e60d7977d06fa991c4afd1ae1f1f3", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOY1RNNTl1Q3RSd1FOQ0RlbzMtemNvckpZcWlXWExnZzA2ZVZVdFNjN19mdE5GQ3g3eTZ1bE5TMGNEZXp1WnNRaVFhMTFXQkhyN0NWVzNCa2VUWF9UYWFjaGdzT2pMSHE2WkNEUlhFS1BzNkxlQVl6cXRTY19JVEg5LWs0am9aRi1RNjVWQmlkRF96YlRUQUpvcmx3Rk93dkh3VHN5Mkp0ZEw1VWMyY3lILS1DRUtfN3E3NVJMTlJ3M0VMTFI4SXk0T3UzNXg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOY1RNNTl1Q3RSd1FOQ0RlbzMtemNvckpZcWlXWExnZzA2ZVZVdFNjN19mdE5GQ3g3eTZ1bE5TMGNEZXp1WnNRaVFhMTFXQkhyN0NWVzNCa2VUWF9UYWFjaGdzT2pMSHE2WkNEUlhFS1BzNkxlQVl6cXRTY19JVEg5LWs0am9aRi1RNjVWQmlkRF96YlRUQUpvcmx3Rk93dkh3VHN5Mkp0ZEw1VWMyY3lILS1DRUtfN3E3NVJMTlJ3M0VMTFI4SXk0T3UzNXg?oc=5", "title": "UK's Hikma Pharmaceuticals posts half-year profit rise as turnaround progresses", "content_text": "UK's Hikma Pharmaceuticals posts half-year profit rise as turnaround progresses", "date_published": "2026-08-06T06:22:34+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:17f8f0d7e8cdd9833d7ee08885d61e79936533fb15684235a201c7259016fdd3", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOSGIxSzlPUzFUdGZpdjJZWGtRek9SeThQMVctWkkzNDY4YUZGTTJSMnBGX3hNQkxUTlNaYnZxMmpZelZJY2hoLXNhaTNacGp3NU4wTV9LU0R2Q1NGZ0JUVjRJaDYtcm1pVzdGQWhmSVNGYVR1dF8wcnN6Y2ZLeUpFbXJyYmVaakhNaWpjc3FiLXFpU2xCYkVLX1JTR2dVQTV6My01dXMtTkthZDhkTjU1U3dZQi01LUpxcF9Hdy1TN05mZGlfSW1kbDVlTQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOSGIxSzlPUzFUdGZpdjJZWGtRek9SeThQMVctWkkzNDY4YUZGTTJSMnBGX3hNQkxUTlNaYnZxMmpZelZJY2hoLXNhaTNacGp3NU4wTV9LU0R2Q1NGZ0JUVjRJaDYtcm1pVzdGQWhmSVNGYVR1dF8wcnN6Y2ZLeUpFbXJyYmVaakhNaWpjc3FiLXFpU2xCYkVLX1JTR2dVQTV6My01dXMtTkthZDhkTjU1U3dZQi01LUpxcF9Hdy1TN05mZGlfSW1kbDVlTQ?oc=5", "title": "Spire Healthcare (LSE:SPI) Brings Capacity Questions Into Focus for UK Healthcare Stocks", "content_text": "Spire Healthcare (LSE:SPI) Brings Capacity Questions Into Focus for UK Healthcare Stocks", "date_published": "2026-08-05T10:33:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "SPI"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SPI", "name": "Spire Healthcare Group plc", "sentiment_url": "https://sharemaestro.com/sentiment/7aa17975-dde1-4419-afb0-f09168c7c1bb/"}]}}, {"id": "source:4d5710230a1946564b91caff3f2461b3fc229356abeddb6beef639b9735d5267", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPV0NoQUc0MTFJWGNRTkMtZC1kVko3Q1FHdU5IbDVITTR2X2NaWkxTRkVWQTlwZFM3dUFvdFRRbUNhbzliTm03aXZwUnBWVmZYNXhyOGVKQURIcWhUUlY1MGU1aEFnR25yVHpQSXZwMUI5TkdxMVlQeml0eklHdjJYbFA4ZGFya0Jk?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPV0NoQUc0MTFJWGNRTkMtZC1kVko3Q1FHdU5IbDVITTR2X2NaWkxTRkVWQTlwZFM3dUFvdFRRbUNhbzliTm03aXZwUnBWVmZYNXhyOGVKQURIcWhUUlY1MGU1aEFnR25yVHpQSXZwMUI5TkdxMVlQeml0eklHdjJYbFA4ZGFya0Jk?oc=5", "title": "Smith & Nephew cuts revenue growth but cost controls pay off", "content_text": "Smith & Nephew cuts revenue growth but cost controls pay off", "date_published": "2026-08-04T16:33:08+00:00", "authors": [{"name": "Investors' Chronicle"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:6c6bd65ecf3d4bab8c63db7bef1834563a8bfb7e0da317b174240c1936aa03c1", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOdFRyMk1aQ1pNbFFaQ3haRDVlQkVhTnAyR1FkY1JycDBHS1FtMHRiSGVEMG5FNV9BVDlORC0zMER6RTVuZ1EwdlRHcG9hSVZUc1I5TEp0SUtWNU5jdU54RW1QcWhHWjVUMlhoWkNJREJESkZDUDlrQk9UYlVIbnlsc3Ixd0pTb09hanAtQ3RKaGRaWVMtdkpWNi1tQnFuTkRGa0hOdG93X3N5bXpCbFhKMVhLMmU?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOdFRyMk1aQ1pNbFFaQ3haRDVlQkVhTnAyR1FkY1JycDBHS1FtMHRiSGVEMG5FNV9BVDlORC0zMER6RTVuZ1EwdlRHcG9hSVZUc1I5TEp0SUtWNU5jdU54RW1QcWhHWjVUMlhoWkNJREJESkZDUDlrQk9UYlVIbnlsc3Ixd0pTb09hanAtQ3RKaGRaWVMtdkpWNi1tQnFuTkRGa0hOdG93X3N5bXpCbFhKMVhLMmU?oc=5", "title": "REG - Verici Dx PLC - Holding(s) in Company", "content_text": "REG - Verici Dx PLC - Holding(s) in Company", "date_published": "2026-08-04T15:29:45+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "VRCI"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VRCI", "name": "Verici Dx plc", "sentiment_url": "https://sharemaestro.com/sentiment/fa544f82-9a09-42e5-8dc5-6311ba031c54/"}]}}, {"id": "source:adfb0decf59d9be1be57992177d7c42639b318257b4e02961410857d225bca55", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPZm9LcVY0dURLcWZ3TUpnNllIZnBNT2lVNlhkSG9JTFNRbzZWenBGWVlzMXh6QTNCZGNCQjFqRE12TFNfUXoySHhmallnVS1wdDhGMFNtWF9BQXdhNUNzXzczOUl4bm5JazhCc3AtWjVDXzBuWmdxWE9aM0w1V3RGeU5xNDVwUjNnODBjdjAzZjNIVFo5eGVlVzhNYlVzM0w0NXQ1bUtSWVRUZEl1OFd0OWl6Yl9yQmUwcUZmNUVzM0tkVVpRWmpVWmgxLUVrRm4yVTYzSlMzZFgyQ3JjNVE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPZm9LcVY0dURLcWZ3TUpnNllIZnBNT2lVNlhkSG9JTFNRbzZWenBGWVlzMXh6QTNCZGNCQjFqRE12TFNfUXoySHhmallnVS1wdDhGMFNtWF9BQXdhNUNzXzczOUl4bm5JazhCc3AtWjVDXzBuWmdxWE9aM0w1V3RGeU5xNDVwUjNnODBjdjAzZjNIVFo5eGVlVzhNYlVzM0w0NXQ1bUtSWVRUZEl1OFd0OWl6Yl9yQmUwcUZmNUVzM0tkVVpRWmpVWmgxLUVrRm4yVTYzSlMzZFgyQ3JjNVE?oc=5", "title": "Smith & Nephew SNATS (NYSE:SNN) Announces Quarterly Earnings Results, Misses Estimates By $0.46 EPS", "content_text": "Smith & Nephew SNATS (NYSE:SNN) Announces Quarterly Earnings Results, Misses Estimates By $0.46 EPS", "date_published": "2026-08-04T15:23:53+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:41b687ef74812b24466dc3706d41691df44c943d0906e9e103ea1968e95a70dc", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNbzRhU1JXS3I1LXN2LTVpZm5uUU02NHBESUxvaTBjd1JpY2dHUDFCUFJyRmNkMDJOd29PSXY4RmlNVEwyYTItRzB1YlZKQWlOUjZLN3NoQnF2dmQ2dkUzaTNnRXNfX29zYVIyTDBIcmJPeVVMRXA0WkNaM0h1TUI5Sy01aTJPdXptU0pFdnZxclk4OE1FSXpHSjBFQVVvRnFiQzRFQg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNbzRhU1JXS3I1LXN2LTVpZm5uUU02NHBESUxvaTBjd1JpY2dHUDFCUFJyRmNkMDJOd29PSXY4RmlNVEwyYTItRzB1YlZKQWlOUjZLN3NoQnF2dmQ2dkUzaTNnRXNfX29zYVIyTDBIcmJPeVVMRXA0WkNaM0h1TUI5Sy01aTJPdXptU0pFdnZxclk4OE1FSXpHSjBFQVVvRnFiQzRFQg?oc=5", "title": "Convatec Group PLC 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:CNVVY) 2026-08-04", "content_text": "Convatec Group PLC 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:CNVVY) 2026-08-04", "date_published": "2026-08-04T15:02:56+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Earnings", "CTEC"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CTEC", "name": "Convatec Group PLC", "sentiment_url": "https://sharemaestro.com/sentiment/7368da00-8a1d-41ac-acb6-1ded5c8b3436/"}]}}, {"id": "source:c60fd0f75f8a676959c8d395fbf4b22b1a601be722f4b1347c9fddbc82530079", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTmg5blFZVENCWHE0VTcweWc1SFNScG1qSms3QllCZkJqanFVMm0xWjBjZGduOW9VSnZLMWxmT3I3RTc3dk9BWUpzZWtHd0lWelF5RTdqVmtPLVcyTWt3X1pvMHBLX3VQQTRpcmJqbXIwMWhFM2hVTEd3QzN6aFAwZG13YVQtMGQ4SU56amtRWDRqNWJyS2VCWi04SUhzRW9rQlAySl9GZWVJaTVXeHJ5QU1oVGk4TWhkazlwdlQySm1vSVQtTnNHamRiUVRnUEdrbjR5Nzd3LTVuX3BkaFV1TUpR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTmg5blFZVENCWHE0VTcweWc1SFNScG1qSms3QllCZkJqanFVMm0xWjBjZGduOW9VSnZLMWxmT3I3RTc3dk9BWUpzZWtHd0lWelF5RTdqVmtPLVcyTWt3X1pvMHBLX3VQQTRpcmJqbXIwMWhFM2hVTEd3QzN6aFAwZG13YVQtMGQ4SU56amtRWDRqNWJyS2VCWi04SUhzRW9rQlAySl9GZWVJaTVXeHJ5QU1oVGk4TWhkazlwdlQySm1vSVQtTnNHamRiUVRnUEdrbjR5Nzd3LTVuX3BkaFV1TUpR?oc=5", "title": "REG - Convatec Group PLC - Further re Interim results for first half of 2026", "content_text": "REG - Convatec Group PLC - Further re Interim results for first half of 2026", "date_published": "2026-08-04T11:43:00+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "CTEC"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CTEC", "name": "Convatec Group PLC", "sentiment_url": "https://sharemaestro.com/sentiment/7368da00-8a1d-41ac-acb6-1ded5c8b3436/"}]}}, {"id": "source:422ea6a5160338167b51ec8270afa63ae2c08fcd466a38659fb81eecad292af8", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNakFOY08xamZJMGJBaEtOWUlBUFk2TWd2LVdTRkF4ME5rZjQ2V2JjaEZjT1JiVWFiWllNWU5CN2RablhvVzVzcTB5a2p4YzRqbUtGM3FKZV9yU0hIVTdpYS1nQWg2WXBSRU01MFFlN3JiMk1PTkd3OWlmYm8xRkNfZUduMWpVZWdSY3BERklYMkNjVWg0ZWFsMWUtMW1RcXdyX1RCSFVwZ0l3aWRGSjkzTw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNakFOY08xamZJMGJBaEtOWUlBUFk2TWd2LVdTRkF4ME5rZjQ2V2JjaEZjT1JiVWFiWllNWU5CN2RablhvVzVzcTB5a2p4YzRqbUtGM3FKZV9yU0hIVTdpYS1nQWg2WXBSRU01MFFlN3JiMk1PTkd3OWlmYm8xRkNfZUduMWpVZWdSY3BERklYMkNjVWg0ZWFsMWUtMW1RcXdyX1RCSFVwZ0l3aWRGSjkzTw?oc=5", "title": "Higher profit but softer sales at Smith+Nephew (NYSE: SNN)", "content_text": "Higher profit but softer sales at Smith+Nephew (NYSE: SNN)", "date_published": "2026-08-04T11:01:33+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:97481d0148803f07e52e46af6cde162df23f1781dc74cf7909cdba61d383d37b", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTThJZERTaXJjaGZFdDBHV1dwVktQRlpFTWo1ZW1kVUlWWFhHTVNGNm1VSWpLTHJNTDBDal91cWxaaURTZzhfRGxYdVZOWjlVNHlRYzVMdk8zTHZBYmR1emx0ZGdSTnpra0V0SUs0NXBtQ0lEZk9DOGQ5RlJIVWp2RkEzUzFiaFBsV0l6dGdyNjVxdDNoYVV4TlUyUUFEdDRzd0ViYWg1QVJXTFdOdDRsd2tWX1J0VUlKLVlXdnNIYmxyaGlzQUZydnhfWQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNTThJZERTaXJjaGZFdDBHV1dwVktQRlpFTWo1ZW1kVUlWWFhHTVNGNm1VSWpLTHJNTDBDal91cWxaaURTZzhfRGxYdVZOWjlVNHlRYzVMdk8zTHZBYmR1emx0ZGdSTnpra0V0SUs0NXBtQ0lEZk9DOGQ5RlJIVWp2RkEzUzFiaFBsV0l6dGdyNjVxdDNoYVV4TlUyUUFEdDRzd0ViYWg1QVJXTFdOdDRsd2tWX1J0VUlKLVlXdnNIYmxyaGlzQUZydnhfWQ?oc=5", "title": "Smith & Nephew plc Reports Earnings Results for the Half Year Ended June 27, 2026", "content_text": "Smith & Nephew plc Reports Earnings Results for the Half Year Ended June 27, 2026", "date_published": "2026-08-04T08:35:58+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:8682c1e5ce05dac0680e161e3420ce38525cd4b97e6221611cd57ff4d9a9e988", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNcjBrRDhlcE43ZDVtbm1SVzZRRUhrSU5lTGNGWkJQQ19kNmhrSVRkMEFnVmUtbGp0SzhqMVpzSnF1ZHk3c3Q1akh6WnU5OFdPcHZrdmo0Q25OM3ZxTWpkN2hMWGtUSkV4eTc5Ml9NXzJVUkFpT2ZmZmVWSjdaUmE3enpidFVzaVVrdExrc0Q3UHAyMER5ZUk5MlQ4eGRpcmFqNmFBeQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNcjBrRDhlcE43ZDVtbm1SVzZRRUhrSU5lTGNGWkJQQ19kNmhrSVRkMEFnVmUtbGp0SzhqMVpzSnF1ZHk3c3Q1akh6WnU5OFdPcHZrdmo0Q25OM3ZxTWpkN2hMWGtUSkV4eTc5Ml9NXzJVUkFpT2ZmZmVWSjdaUmE3enpidFVzaVVrdExrc0Q3UHAyMER5ZUk5MlQ4eGRpcmFqNmFBeQ?oc=5", "title": "Why Is Smith & Nephew (LSE:SN) Facing Fresh Market Attention?", "content_text": "Why Is Smith & Nephew (LSE:SN) Facing Fresh Market Attention?", "date_published": "2026-08-04T08:25:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:89399de60182b8260d2729215cfc30bb88035051c675f95519315345e614894c", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQSUpxMDI4VTJqMFZXRVlOZTJxam01MV9MZEFVNWs4WU1LZjZjcGZvMlZXZjctOUhacFlxQWxnaktjdFVtYUt4b2c1V2pva1RTNm5TRVhJNkRCYU1zTjJyTUFucGtrUEJrVkpTMFlYd2Fmbm9hOHB3Zjd3THdfc0lrejBoNDNnSjMydHVmWWFQVlBiVXBGVTkxWUczWVVhVHZ1VmN1SDB0cWk1azRXUmZWSk9KYUpsb0tTd0NTcVlXQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQSUpxMDI4VTJqMFZXRVlOZTJxam01MV9MZEFVNWs4WU1LZjZjcGZvMlZXZjctOUhacFlxQWxnaktjdFVtYUt4b2c1V2pva1RTNm5TRVhJNkRCYU1zTjJyTUFucGtrUEJrVkpTMFlYd2Fmbm9hOHB3Zjd3THdfc0lrejBoNDNnSjMydHVmWWFQVlBiVXBGVTkxWUczWVVhVHZ1VmN1SDB0cWk1azRXUmZWSk9KYUpsb0tTd0NTcVlXQQ?oc=5", "title": "Smith & Nephew SNATS (NYSE:SNN) Trading Down 5.8% on Disappointing Earnings", "content_text": "Smith & Nephew SNATS (NYSE:SNN) Trading Down 5.8% on Disappointing Earnings", "date_published": "2026-08-04T07:00:00+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:f56867c76857034ed0b961ac446fb96b5a15782733dbc11cb541c99f4280c48e", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNYlJKdVRVR1V5aDB1QXMtQmVla2NIUzE2U3hDQUlON3E1LVhLSUItT0w4WWR0VGZ1a3RUR2kxNEozcG50bUdRWjFRZ29ka3RkT2xYaEF4UVBZcVNJc092c2h2T2NlNWpyZ1RyY3cyQk5wNlNEdW9fQkRiYVJiX2VTU0NSbWxacG9NZ2lqenNJLTVfa2w4cXBtWDJNaVBfdlRhYWtrNFNDQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNYlJKdVRVR1V5aDB1QXMtQmVla2NIUzE2U3hDQUlON3E1LVhLSUItT0w4WWR0VGZ1a3RUR2kxNEozcG50bUdRWjFRZ29ka3RkT2xYaEF4UVBZcVNJc092c2h2T2NlNWpyZ1RyY3cyQk5wNlNEdW9fQkRiYVJiX2VTU0NSbWxacG9NZ2lqenNJLTVfa2w4cXBtWDJNaVBfdlRhYWtrNFNDQQ?oc=5", "title": "Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2026-08-04", "content_text": "Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:SNN) 2026-08-04", "date_published": "2026-08-04T07:00:00+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Earnings", "SN"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SN", "name": "Smith & Nephew plc", "sentiment_url": "https://sharemaestro.com/sentiment/89509977-afe3-498f-a473-af6eac850d5c/"}]}}, {"id": "source:15c08a44f72c71a24a2fc6a5d7b77afd5b295561a0723e7726863eb000d31832", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQZ3RnaGNKU0pEekJoWWRVcWFrUHVwVU9mWUxPaW95RTJPQkhOUEpLM0daTlJzN0VIMHc5SkZDbENIdzRpSDJlVk13clZuWVgtcHN0ZXZJNWJIM2NWam4wY2xTNm16THpBV1VwOHQxT29wTUkyYjgtUmRkVWxLOHBIaUVRTGZSZWtqalVHVVl3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQZ3RnaGNKU0pEekJoWWRVcWFrUHVwVU9mWUxPaW95RTJPQkhOUEpLM0daTlJzN0VIMHc5SkZDbENIdzRpSDJlVk13clZuWVgtcHN0ZXZJNWJIM2NWam4wY2xTNm16THpBV1VwOHQxT29wTUkyYjgtUmRkVWxLOHBIaUVRTGZSZWtqalVHVVl3?oc=5", "title": "BSF Enterprise Shares Rises 47% on T-Rex Leather expansion", "content_text": "BSF Enterprise Shares Rises 47% on T-Rex Leather expansion", "date_published": "2026-08-03T08:41:33+00:00", "authors": [{"name": "Share Talk"}], "tags": ["Market update", "BSFA"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BSFA", "name": "BSF Enterprise Plc", "sentiment_url": "https://sharemaestro.com/sentiment/171311db-1960-476e-9986-f23ed513228a/"}]}}, {"id": "source:b9ebf61deb736f491aa6504639e53a9a43c791f106c704f1cd999d7881eb3b97", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxORXc3TDJKeVlwSUt3d0pFLVJLY2NXOWp6ZlNIRkk2cTM1b2QxeVpxSHQ3TkhOazlzMDNWVHh4MDZWa0phN3R0Z2xjM05TdzdsN3dZVXVPT0FDeTQyZ2QzYkhWN1pNWU03WHpWVEphazNhS1RHR1IwajA4bjZIU0p0b1AtOThaRUhmQzctRGxrUFRDLVJ3aF9XdXlIUHFZNFRwTlUwNHRoY05qXzhqeXFKUHN0VURyaU9nc3ZRcklXYVR0UWh1?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxORXc3TDJKeVlwSUt3d0pFLVJLY2NXOWp6ZlNIRkk2cTM1b2QxeVpxSHQ3TkhOazlzMDNWVHh4MDZWa0phN3R0Z2xjM05TdzdsN3dZVXVPT0FDeTQyZ2QzYkhWN1pNWU03WHpWVEphazNhS1RHR1IwajA4bjZIU0p0b1AtOThaRUhmQzctRGxrUFRDLVJ3aF9XdXlIUHFZNFRwTlUwNHRoY05qXzhqeXFKUHN0VURyaU9nc3ZRcklXYVR0UWh1?oc=5", "title": "Why Genflow Biosciences (LSE:GENF) Is Drawing Fresh Attention in Longevity Research", "content_text": "Why Genflow Biosciences (LSE:GENF) Is Drawing Fresh Attention in Longevity Research", "date_published": "2026-08-03T07:11:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "GENF"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "GENF", "name": "Genflow Biosciences plc", "sentiment_url": "https://sharemaestro.com/sentiment/58fbeadf-36df-4bee-b1a6-fb9a51481ba7/"}]}}, {"id": "source:bc51b29c10c779fac11fde560421491317846428053d74e582b631ffffdc4ad5", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNzhRSEdrbDBCRmFzTmlpSi1VUXNlQm83UlFEcVdJY1ZTaU95OE5wMU42R2ZGalYxM3JvR0pwVHRWUlZLcjBBMng3LWhjbGpwaDd3bllHRGJMNGdyU09uQnY4RU5PdUJsdUhsTEtXUEdiSU1xcmJ5Mi1NbFhZMXRtVGlWdm5tS3d4ekRUTmRMSlNkSXpDVHhzOUh1TFAwMGFLX3MyOS11aEVuWWUwaFpyYWw2RXBPZE5Sc3NDWkF5VXlvUUIybW1WRmNn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNzhRSEdrbDBCRmFzTmlpSi1VUXNlQm83UlFEcVdJY1ZTaU95OE5wMU42R2ZGalYxM3JvR0pwVHRWUlZLcjBBMng3LWhjbGpwaDd3bllHRGJMNGdyU09uQnY4RU5PdUJsdUhsTEtXUEdiSU1xcmJ5Mi1NbFhZMXRtVGlWdm5tS3d4ekRUTmRMSlNkSXpDVHhzOUh1TFAwMGFLX3MyOS11aEVuWWUwaFpyYWw2RXBPZE5Sc3NDWkF5VXlvUUIybW1WRmNn?oc=5", "title": "Hikma Pharmaceuticals stock gains a sharper investment case for August UK portfolios", "content_text": "Hikma Pharmaceuticals stock gains a sharper investment case for August UK portfolios", "date_published": "2026-08-01T07:00:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "HIK"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "sentiment_url": "https://sharemaestro.com/sentiment/6c02db42-433d-4918-8688-945b0edead32/"}]}}, {"id": "source:bec8b93b84124a6828f54005649fe8790231ccbca983344d41501c3662937791", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFByaVN1bm1PTThJeWFkbGJIcnpwOWNFcGJsZHVLbmVGOUlxVDloaHkxYkZob185SFhMNm9iN0g2V3BDTTdmbnVpUlRPdU1iQ25yV3VWd1F6eTFCZmpOZXZaM3VLTFBGYVdSOGIyeTdGQUZpWjg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFByaVN1bm1PTThJeWFkbGJIcnpwOWNFcGJsZHVLbmVGOUlxVDloaHkxYkZob185SFhMNm9iN0g2V3BDTTdmbnVpUlRPdU1iQ25yV3VWd1F6eTFCZmpOZXZaM3VLTFBGYVdSOGIyeTdGQUZpWjg?oc=5", "title": "Avacta Group PLC Revenue Breakdown \u2013 LSE:AVCT", "content_text": "Avacta Group PLC Revenue Breakdown \u2013 LSE:AVCT", "date_published": "2026-08-01T05:37:49+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "AVCT"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AVCT", "name": "Avacta Group Plc", "sentiment_url": "https://sharemaestro.com/sentiment/6c180d20-8da0-4454-85c4-602c9b980498/"}]}}, {"id": "source:63659b4577f49965ddf29afff7cbd01d651f03d501c7fc4594ab6e3066fa2ddf", "url": "https://news.google.com/rss/articles/CBMickFVX3lxTE1oYzNFaXVtNGlFTDhweTFBTWI2YWVsY1VHd1paZFJ5b2JMZDFOaUpYT3dBU1ozN3RmZWhoQmU3blBVYU5vYlUxNGpjMWVTSHozeXZ2SlNVRlJESnQxN1hpOEtadWFzcXhjUFIxeEllcDgwUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMickFVX3lxTE1oYzNFaXVtNGlFTDhweTFBTWI2YWVsY1VHd1paZFJ5b2JMZDFOaUpYT3dBU1ozN3RmZWhoQmU3blBVYU5vYlUxNGpjMWVTSHozeXZ2SlNVRlJESnQxN1hpOEtadWFzcXhjUFIxeEllcDgwUQ?oc=5", "title": "Allergy Therapeutics plc Revenue Breakdown \u2013 LSE:AGY", "content_text": "Allergy Therapeutics plc Revenue Breakdown \u2013 LSE:AGY", "date_published": "2026-08-01T05:31:01+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "AGY"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AGY", "name": "Allergy Therapeutics plc", "sentiment_url": "https://sharemaestro.com/sentiment/fb7a4948-aa80-4e65-aa8e-6e4c41924459/"}]}}, {"id": "source:a55dc77dcc7f33738dba46d942590f7357e485a829c106498dc204eaa4ce8d19", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE10UkZwMGRoaTgzVTJzSU00NE8zRVB1MjY3YXRBV1diZi1iQzNfYkw2bDhaTEVoV0EwRWU5Sk1TZDhHQXo2azM2YlF3Um9CZEZOYzdTZjJxVjduQ1NsRDFUeE1ERXFQVW5jUmRJQ1AxMUpPeE0?oc=5", "external_url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE10UkZwMGRoaTgzVTJzSU00NE8zRVB1MjY3YXRBV1diZi1iQzNfYkw2bDhaTEVoV0EwRWU5Sk1TZDhHQXo2azM2YlF3Um9CZEZOYzdTZjJxVjduQ1NsRDFUeE1ERXFQVW5jUmRJQ1AxMUpPeE0?oc=5", "title": "Scancell Holdings Plc Revenue Breakdown \u2013 LSE:SCLP", "content_text": "Scancell Holdings Plc Revenue Breakdown \u2013 LSE:SCLP", "date_published": "2026-07-31T22:33:53+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "SCLP"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCLP", "name": "Scancell Holdings plc", "sentiment_url": "https://sharemaestro.com/sentiment/91b90cf7-eff9-429e-8365-4b7d09e6821c/"}]}}, {"id": "source:b47d688c981c0a32cf0797ba5bca51f55cdbd6b6bb9c810999ce894d424ada1a", "url": "https://news.google.com/rss/articles/CBMickFVX3lxTE5LVDdMRWt3X3gxSHBlNnFXUkszOGZtM0xFZVE5aEJjbHhabENFbGJKa0JaaWY4NkhMeGhVbkRFUmVnQzZhM1JiNzBqcGxyRWdCRURrYzdSS1ZDbmpWeWdNZlJ5aWhXYXpSZ1RrTVJ3WGFmQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMickFVX3lxTE5LVDdMRWt3X3gxSHBlNnFXUkszOGZtM0xFZVE5aEJjbHhabENFbGJKa0JaaWY4NkhMeGhVbkRFUmVnQzZhM1JiNzBqcGxyRWdCRURrYzdSS1ZDbmpWeWdNZlJ5aWhXYXpSZ1RrTVJ3WGFmQQ?oc=5", "title": "Shield Therapeutics Plc Revenue Breakdown \u2013 LSE:STX", "content_text": "Shield Therapeutics Plc Revenue Breakdown \u2013 LSE:STX", "date_published": "2026-07-31T18:44:32+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "STX"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "STX", "name": "Shield Therapeutics plc", "sentiment_url": "https://sharemaestro.com/sentiment/d3a100b9-3c72-4fc3-804e-4ee20933002d/"}]}}, {"id": "source:5ba54d8d75d41ab2dd845f880bdfd44cd0a7d2d1466d2e87a0f1e9bad9af13a3", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbXZkbVpwQ1BDRlYwTnhVc09oa2MyUHVkMFVPMG9SMVNkQ1U1Q0xoV28zaWlmQ3NtREJ1b3pwYTIxcXNRdGs4V0Q4aGRVenVGNGtnNWsybkV5ZnZnc2xTOEROWW9OVXlXazB6VkFIc1h3Z1o5VjhrY3FwbVJaYkJQRkFEamF3R1JlelB4YTZPTUszVXh6X3UzWVo5UkVmaEwzZ3FtNTJnaV93VTlXVWFKT25iTm1sZTlXeU53NkQ5TjV6YjdL?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbXZkbVpwQ1BDRlYwTnhVc09oa2MyUHVkMFVPMG9SMVNkQ1U1Q0xoV28zaWlmQ3NtREJ1b3pwYTIxcXNRdGs4V0Q4aGRVenVGNGtnNWsybkV5ZnZnc2xTOEROWW9OVXlXazB6VkFIc1h3Z1o5VjhrY3FwbVJaYkJQRkFEamF3R1JlelB4YTZPTUszVXh6X3UzWVo5UkVmaEwzZ3FtNTJnaV93VTlXVWFKT25iTm1sZTlXeU53NkQ5TjV6YjdL?oc=5", "title": "Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances", "content_text": "Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances", "date_published": "2026-07-31T10:32:39+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "THAT"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "THAT", "name": "Thalia Therapeutics Plc", "sentiment_url": "https://sharemaestro.com/sentiment/c28ab7d4-d7c3-411b-9d99-17587fd08379/"}]}}, {"id": "source:48972934cd4ef3c30ce5b4a0e0495acf4b0dc2ba6646bcf5b4140cf5cee2d44f", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Loss-Making Shield Therapeutics plc (LON:STX) Expected To Breakeven In The Medium-Term", "content_text": "Loss-Making Shield Therapeutics plc (LON:STX) Expected To Breakeven In The Medium-Term", "date_published": "2026-07-31T07:00:00+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "STX"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "STX", "name": "Shield Therapeutics plc", "sentiment_url": "https://sharemaestro.com/sentiment/d3a100b9-3c72-4fc3-804e-4ee20933002d/"}]}}, {"id": "source:3b274f62c6191515cd30273950d0d60afbc0e7f9d36e10232c6c9c16b6b05f3e", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZEE0bF9fZlRUb25HWkF4Zi1hampDQlRuSVpscWhvbEZEeTdSckdsbWR6aHR3S281VkRPWlZiOFRGNWYtamdjSllzNy1PU1lIQ2xXWElja1ZhREd1NlgzU2Z5dzk0Skg4UFg2VXJDOW0wSjZwbEh5WDRpUmZzZF9iVFZTLTdGQW9kbTYxREc0TGdZOE56TEpTVTlCS2d2c2ZUU2JIeWowV2RCY0dfSlRoT01Dc21BRmM4UE51cVNOWEU3RkIxVC1jeHA0WThqZFd6N3J1TUk1eHY?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZEE0bF9fZlRUb25HWkF4Zi1hampDQlRuSVpscWhvbEZEeTdSckdsbWR6aHR3S281VkRPWlZiOFRGNWYtamdjSllzNy1PU1lIQ2xXWElja1ZhREd1NlgzU2Z5dzk0Skg4UFg2VXJDOW0wSjZwbEh5WDRpUmZzZF9iVFZTLTdGQW9kbTYxREc0TGdZOE56TEpTVTlCS2d2c2ZUU2JIeWowV2RCY0dfSlRoT01Dc21BRmM4UE51cVNOWEU3RkIxVC1jeHA0WThqZFd6N3J1TUk1eHY?oc=5", "title": "Animalcare Group (ANCR) Delists from AIM Following Completion of Charterhouse-Backed Acquisition", "content_text": "Animalcare Group (ANCR) Delists from AIM Following Completion of Charterhouse-Backed Acquisition", "date_published": "2026-07-31T06:01:33+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Deals and strategy", "ANCR"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ANCR", "name": "Animalcare Group plc", "sentiment_url": "https://sharemaestro.com/sentiment/d0427923-5894-4886-9632-f4614cce1f17/"}]}}, {"id": "source:c0fadaa2fcddfb06155ec1bb216fd235b4d19cbf7bd5dae284b7ec12915d583e", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOdE83c3A2Ti1JeVREZnZqeWkzYjg2TlozZXdKQ2tyLWhxZmJTYWpveUJCTUZ6WldWdFpJelpmb2ppeC12MkRWcHZHdk1uYWdOdmlZMWQ1VVBIMXVuM1ozNTVkUHQ5SzB2OWp6V2Z5YUtsRl93Q3BfYUFHOUtqbHk3MjdIU05UVUR3cnBzbW1Vajd1MFJkOUszSTBhbWNlMmlYNWY5akk2bHM4SFBacEt5OXkwdW1Yd2tXU2hnNm9sX2JDWHhZY09VakYyVQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOdE83c3A2Ti1JeVREZnZqeWkzYjg2TlozZXdKQ2tyLWhxZmJTYWpveUJCTUZ6WldWdFpJelpmb2ppeC12MkRWcHZHdk1uYWdOdmlZMWQ1VVBIMXVuM1ozNTVkUHQ5SzB2OWp6V2Z5YUtsRl93Q3BfYUFHOUtqbHk3MjdIU05UVUR3cnBzbW1Vajd1MFJkOUszSTBhbWNlMmlYNWY5akk2bHM4SFBacEt5OXkwdW1Yd2tXU2hnNm9sX2JDWHhZY09VakYyVQ?oc=5", "title": "HUTCHMED Limited Reports Earnings Results for the Half Year Ended June 30, 2026", "content_text": "HUTCHMED Limited Reports Earnings Results for the Half Year Ended June 30, 2026", "date_published": "2026-07-30T19:22:23+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "HCM"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCM", "name": "HUTCHMED (China) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/bd4ead73-4b29-40ea-8a27-22590ab302da/"}]}}, {"id": "source:0aa071f242532fa24883e4e5867d1d66d095e8a5091a24fe6404857b758b94e9", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxObnQxRksxX2p3Rmg0X0xTbU5vNWRyaXhPUDFaT0NxQlQ2YWhXWFkxZk1ybm9mVTh2OFA3RHlTcXJCSGJwOVV3OW4tNjdUeEgwdjVRUnBrS2NpNHhGOEYwMlhBZl9CV1VON21ZT3YwbHVsRmNPYThoMjZNbVM4cFdHRjRkaGhySHFFVWZiQ0lZdWVkZmVTVWJDekpGWFF2cFNrODY2ZTJkUHVFTTk1UWpyOXFzMG5rS0xVWWl6MHowSDlXNkxxUE5hLW5pWXdJT0tidjMzcll2VFpIWDRUY0Y2MU9B?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxObnQxRksxX2p3Rmg0X0xTbU5vNWRyaXhPUDFaT0NxQlQ2YWhXWFkxZk1ybm9mVTh2OFA3RHlTcXJCSGJwOVV3OW4tNjdUeEgwdjVRUnBrS2NpNHhGOEYwMlhBZl9CV1VON21ZT3YwbHVsRmNPYThoMjZNbVM4cFdHRjRkaGhySHFFVWZiQ0lZdWVkZmVTVWJDekpGWFF2cFNrODY2ZTJkUHVFTTk1UWpyOXFzMG5rS0xVWWl6MHowSDlXNkxxUE5hLW5pWXdJT0tidjMzcll2VFpIWDRUY0Y2MU9B?oc=5", "title": "HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of \"Hold\" from Brokerages", "content_text": "HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of \"Hold\" from Brokerages", "date_published": "2026-07-30T07:00:00+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Analyst action", "HCM"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCM", "name": "HUTCHMED (China) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/bd4ead73-4b29-40ea-8a27-22590ab302da/"}]}}, {"id": "source:1ca320e2bbde30fe6de6aa791ae340d15c8f808a6e8afee1a9a9438a262a0147", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQbGQzeHI5c3VyWVlCR0dzcXktZFN6MjNOMlVUdmZ0ejJLVWJnQU9HS1VzRkM4dWRaSHdZSmFYTWRza21YU3B4TzJSMTRZVDZsZnFPV0hNSHRoNEhTLU9nYTY0VjBHMU5yZ2gxaHFzaFR1ZkZqSEJ2MGM2OTdZZDJuclFYbF84ZE96cGNvdmwtUEdjcHdtdjd0UVdXX01VcEFsd0JtbmpuazFRZw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQbGQzeHI5c3VyWVlCR0dzcXktZFN6MjNOMlVUdmZ0ejJLVWJnQU9HS1VzRkM4dWRaSHdZSmFYTWRza21YU3B4TzJSMTRZVDZsZnFPV0hNSHRoNEhTLU9nYTY0VjBHMU5yZ2gxaHFzaFR1ZkZqSEJ2MGM2OTdZZDJuclFYbF84ZE96cGNvdmwtUEdjcHdtdjd0UVdXX01VcEFsd0JtbmpuazFRZw?oc=5", "title": "HUTCHMED (China) Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HCM) 2026-07-30", "content_text": "HUTCHMED (China) Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HCM) 2026-07-30", "date_published": "2026-07-30T07:00:00+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Earnings", "HCM"], "_sharemaestro": {"country": "United Kingdom", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCM", "name": "HUTCHMED (China) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/bd4ead73-4b29-40ea-8a27-22590ab302da/"}]}}]}